Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

71967197719871997200720172027203720472057206720772087209721072117212721372147215721672177218721972207221722272237224722572267227722872297230723172327233723472357236723772387239724072417242724372447245724672477248Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients withcolorectal carcinoma. Abdom Imaging 2004; 29:663-666.Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW et al. Open versus laparoscopic surgery for mid orlow rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-labelrandomised controlled trial. Lancet Oncol. 2010 Jul;11(7):637-45.Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapycombined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.Kantorová I, Lipská L, Belohlávek O, Visokai V, Trubaĉ M, Scheiderová M. Routine 18F-FDG-PET preoperativestaging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.J Nucl Med 2003;44:1784-8.Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC et al. K-ras mutations andbenefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008 Oct 23;359(17):1757-65. doi:10.1056/NEJMoa0804385.Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) forlimited hepatic metastases. Int J Radiat Oncol Biol Phys 2007 Mar 1;67(3):793-8.Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) foroligometastases. Semin Radiat Oncol 2006 Apr;16(2):77-84.Keating J, Lolohea S, Kenwright D. Pathology reporting of rectal cancer: a national audit. N Z Med J2003;116:U514.Keeling AN, Slattery MM, Leong S, McCarthy E, Susanto M, Lee MJ, Morrin MM. Limited-preparation CTcolonography in frail elderly patients: a feasibility study. AJR Am J Roentgenol. 2010 May;194(5):1279-87. doi:10.2214/AJR.09.2896.Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: acase study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan;9(1):13-25.Review.Kemeny N, Daly J, Reichmann B, et al: Intrahepatic or systemic infusion of fluorodeoxuridine in patients with livermetastasen from colorectal carcinoma.Ann Internal Med 1987;107:459-465.Kemeny N, Cohen A, Seiter K, et al: Randomized trial of hepatic arterial floxuridine, mitomycin and carmustineversus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol1993;11:330-335.Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepaticmetastases from colorectal cancer. N Engl J Med 1999; 341:2039-2048.Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine anddexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.J ClinOncol 2001; 19:2687-2695Kennedy ED, Schmocker S, Victor C, Baxter NN, Kim J, Brierley J, McLeod RS. Do patients considerpreoperative chemoradiation for primary rectal cancer worthwhile? Cancer. 2011 Jul 1;117(13):2853-62. doi:10.1002/cncr.25842. Epub 2011 Jan 10.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 169